Why ‘high fibre’ rarely means what you think

To consumers, it sounds reassuring. To food brands, it feels safe. To regulators, it’s anything but simple.

Behind that short phrase sits a web of definitions, dose thresholds, fibre types, and physiological effects that are often oversimplified – or misunderstood entirely. And that’s where brands get into trouble.

Fibre isn’t one thing, and the body doesn’t treat it as such

Dietary fibre is an umbrella term. From a physiological perspective, different fibres behave very differently in the body. They differ by solubility, fermentability, viscosity, and physiological target – meaning the specific outcome a fibre can support depends entirely on its type.

Insoluble fibres may primarily support stool bulk and transit time. Viscous soluble fibres can influence cholesterol absorption or post-prandial glucose response. Fermentable fibres may affect gut microbiota composition and short-chain fatty acid production.

Yet many products group all fibre together in their claims, even when the stated benefit only applies to a specific fibre type. That misalignment is where compliance risk begins.

Dose matter more than presence

One of the most common mistakes brands make is assuming that adding any amount of fibre is enough to support a meaningful claim. From a regulatory and physiological perspective, that’s rarely true.

Two distinct issues arise. The first is minimum claim thresholds – regulatory frameworks set quantitative cut-offs for claims like “source of fibre” or “high fibre,” and meeting that threshold allows the wording but does not guarantee a health outcome. The second is the gap between effective dose and label dose. Many fibres only demonstrate physiological effects at doses well above what a typical serve delivers. If a study shows benefit at 10–15g per day but a product provides 2g per serve, the translation from evidence to claim is weak at best.

This disconnect is one of the fastest ways to drift into implied or overstated claims – often without realising it.

Not all fibre delivers the same physiological effect

A product may be legitimately “high fibre” yet unable to support the benefit consumers assume it delivers. Satiety claims require viscous or fermentable fibres. Gut health claims require evidence of fermentability. Cholesterol-related implications require beta-glucans or equivalent fibres. Glycaemic positioning requires fibres that have been shown to alter glucose response.

The problem isn’t fibre itself – it’s over-generalisation. When claims imply outcomes that rely on specific mechanisms, regulators expect those mechanisms to be both plausible and supported by relevant evidence.

“High fibre” ≠ a free pass for broader health claims

Because fibre carries a strong health halo, it’s tempting to let a “high fibre” call-out do more work than it’s permitted to. But fibre content alone does not automatically justify weight management messaging, heart health positioning, blood sugar claims, or gut microbiome promises.

Each of those outcomes requires the right fibre type, at the right dose, with evidence that aligns to the specific claim wording. Without that alignment, brands risk crossing from factual content claims into unsupported health claims – even unintentionally.

Why fibre claims are increasingly scrutinised

Globally, fibre claims are under growing regulatory attention because they sit at the intersection of consumer trust, functional food positioning, and evidence-based substantiation. In Australia, fibre claims are governed by the Food Standards Code and assessed within the broader health claim compliance framework overseen by Food Standards Australia New Zealand.

What regulators are asking is not simply whether the fibre is present. They are asking whether the claim accurately reflects what that fibre, at that dose, can reasonably do. That distinction is where many labels quietly fail.

What food brands should do instead

Strong fibre positioning doesn’t come from louder claims – it comes from better alignment. That means understanding the specific fibre type in your formulation, mapping claims to mechanism-appropriate outcomes, sense-checking dose against the evidence, using precise and defensible wording rather than broad health halos, and assessing claim feasibility before artwork goes to print.

This approach doesn’t limit your marketing. It reduces risk, avoids costly reprints, and builds long-term consumer trust.

Final takeaway

“High fibre” is one of the safest-sounding claims on pack – and one of the easiest to misuse. When fibre type, dose, and physiological effect aren’t aligned, a claim may pass a surface-level check while quietly creating compliance risk underneath.

Getting fibre claims right isn’t about avoiding fibre. It’s about being specific, restrained, and evidence-aligned. That’s where strong brands win.

Food labelling and health claims are complex, and most brands are never taught how to navigate them properly. Labelled & Legit is designed to give food brands clarity, confidence, and a defensible framework for getting labels and claims right before launch. Join the Labelled & Legit waitlist here.